Fonte: Clinical Cancer Research. Unidade: FM
Assuntos: METALOPROTEINASES, ADENOCARCINOMA
ABNT
PINTO, Clovis Antônio et al. Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung. Clinical Cancer Research, v. 9, 2003Tradução . . Acesso em: 12 set. 2024.APA
Pinto, C. A., Carvalho, P. E. de O., Antonangelo, L., Garippo, A., Silva, A. G. P. da, Soares, F., et al. (2003). Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung. Clinical Cancer Research, 9.NLM
Pinto CA, Carvalho PE de O, Antonangelo L, Garippo A, Silva AGP da, Soares F, Younes R, Beyruti R, Takagaki T, Saldiva PHN, Vollmer RT, Capelozzi VL. Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung. Clinical Cancer Research. 2003 ; 9[citado 2024 set. 12 ]Vancouver
Pinto CA, Carvalho PE de O, Antonangelo L, Garippo A, Silva AGP da, Soares F, Younes R, Beyruti R, Takagaki T, Saldiva PHN, Vollmer RT, Capelozzi VL. Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung. Clinical Cancer Research. 2003 ; 9[citado 2024 set. 12 ]